About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $15.22 | Open | $15.12 |
| Volume | 3.5M | Market Cap | 5.403B |
| Yield | Last Dividend |
| FDA Approves Bausch + Lomb Alaway?? Pres... | 09/25/20 |
| LAVAL, QC and DEER PARK, Ill., Sept. 25, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), Bausch + Lomb, a leading... | |
| The Week Ahead In Biotech: Conference Pr... | 09/20/20 |
| Biotech stocks found themselves among gains in the week ended Sept. 18, with conference presentations, IPO news flow and updates on coronavirus vaccin... | |
| Bausch Health Companies Inc. (BHC) Manag... | 09/17/20 |
| Bausch Health Companies Inc. (NYSE:BHC) Morgan Stanley Global Healthcare Conference September 16, 2020 13:15 ET Corporate Participants Joe Papa - Chai... | |
| Bausch Health (BHC) Presents At Morgan S... | 09/17/20 |
| The following slide deck was published by Bausch Health Companies Inc. in conjunction with this event.. | |
| Global Eyewear Market- Featuring Bausch ... | 09/16/20 |
| LONDON--(BUSINESS WIRE)-- #EyewearMarket--The Global Eyewear Market will grow by USD 57.69 bn during 2020-2024 | |
| Bausch Health Provides Company Update At... | 09/16/20 |
| LAVAL, Quebec, Sept. 16, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it has p... | |
| The Week Ahead In Biotech: Decision Day ... | 09/13/20 |
| Biotech stocks continued to remain under pressure in the week ended Sept. 11, swayed by the volatility that was evident in the broader market. The wee... | |
| Bausch Foundation Releases Inaugural Act... | 09/10/20 |
| LAVAL, Quebec, Sept. 10, 2020 /PRNewswire/ -- The Bausch Foundation ("Foundation"), which oversees and directs the charitable giving efforts of Bausch... | |
| Bausch Health To Participate At The 18th... | 09/09/20 |
| LAVAL, QC, Sept. 9, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and CEO; Sam Eldes... | |
| Attention Biotech Investors: Mark Your C... | 09/01/20 |
| August was a disappointing month as far as regulatory decisions are concerned. The FDA turned down several applications, citing different reasons. Not... | |
| Bausch + Lomb India urges consumers to ?... | 08/31/20 |
| The digital campaign encourages people look at the positive lifestyle changes that have come along the last few months | |
| Bausch Health To Reduce Debt By $100 Mil... | 08/31/20 |
| LAVAL, QC, Aug. 31, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduc... | |
| Dr Reddy's launches Wilson's disease and... | 08/27/20 |
| New Delhi: Pharma major Dr Reddy's Laboratories on Thursday said it has launched generic Penicillamine capsules, used for treatment of Wilson's diseas... | |
| Why Teva and Bausch Health Are Under-per... | 08/25/20 |
| Teva (NYSE:TEVA) continues to trade at a discount because of its Cephalon unit. The opioid crisis is still a headwind hurting the stock. On Aug. 18, N... | |
| Pete Najarian Sees Unusual Activity In M... | 08/20/20 |
| On CNBC's "Fast Money Halftime Report," Pete Najarian said options traders were buying the August $87 calls in Merck & Co., Inc. ??? | |
| Bausch + Lomb Launches Innovative Bausch... | 08/17/20 |
| Next Generation Material Infused with Proprietary ProBalance Technology??? to Help Maintain Ocular Surface Homeostasis and Help Reduce Contact Lens Dr... | |
| Health Canada Approves BAUSCH + LOMB ULT... | 08/11/20 |
| LAVAL, QC, Aug. 11, 2020 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch ... | |
| The Week Ahead In Biotech: Bausch Health... | 08/09/20 |
| Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and c... | |
| United States Acne and Rosacea Industry ... | 08/07/20 |
| DUBLIN, Aug. 7, 2020 /PRNewswire/ -- The "US Acne & Rosacea Market: Insights, Trends & Forecast (2020-2024)" report has been added to ResearchAndMarke... | |
| Analyzing Bausch Health's Unusual Option... | 08/07/20 |
| On Friday, shares of Bausch Health Cos (NYSE: BHC) saw unusual options activity. After the option alert, the stock price moved down to $18.14. Sentime... | |
| Ophthalmic Lens Market Analysis Highligh... | 08/06/20 |
| Technavio has been monitoring the ophthalmic lens market and it is poised to grow by USD 3.21 billion during 2020-2024, progressing at a CAGR of over ... | |
| OraSure, Becton, Dickinson fall; Bausch,... | 08/06/20 |
| Stocks that moved heavily or traded substantially on Thursday: OraSure, Becton, Dickinson fall; Bausch, Vista Outdoor rise | |
| Why Bausch Health Stock (TSX:BHC) Is Ral... | 08/06/20 |
| Despite the coronavirus pandemic, Bausch Health Companies stock continues rallying as the company spins off of its eye heath business. The post Why Ba... | |
| Jim Cramer: I Like Bausch, But Bristol-M... | 08/06/20 |
| Jim Cramer weighs in on Bausch and its pan to spin off its eye-care division. | |
| Bausch Health To Spin Off Eye Care Busin... | 08/06/20 |
| Shares in Bausch Health Companies spiked 18% as the Canadian drugmaker announced a plan to spin off its eye health care business, Bausch ??? The post ... | |
| CANADA STOCKS-TSX scales 5-month high on... | 08/06/20 |
| Canada's main stock index scaled a five-month high on Thursday as a surge in shares of drugmaker Bausch Health and higher oil prices outweighed disapp... | |
| Bausch Health Shares Soar On Baush & Lom... | 08/06/20 |
| Bausch Health shares surged higher Thursday after the company said it plans to spin-off is Bausch & Lomb eyecare division into a separate business. | |
| Stocks making the biggest moves in the p... | 08/06/20 |
| The stocks making the biggest moves in premarket trading include Hilton, Restaurant Brands, Bausch Health, and more. | |
| Bausch Health shares soar 23% premarket ... | 08/06/20 |
| Bausch Health Cos. shares undefined soared 23% in premarket trade Thursday, after a Wall Street Journal report that the company is planning to spin of... | |
| Bausch Health to Spin Off Eye-Care Busin... | 08/06/20 |
| Bausch Health plans to spin off its faster-growing eye-care business from its core pharmaceutical operations, breaking apart a company previous manage... | |
| Hold rating | 09/17/20 |
| B of A Securities upgrades from Underperform to Neutral rating and raises Price Target from $16.00 to $19.00 | |
| Buy rating | 08/24/20 |
| HC Wainwright & Co. maintains Buy rating and lowers Price Target from $64.00 to $50.00 | |
| Strong Buy rating | 08/19/20 |
| Piper Sandler maintains Overweight rating and lowers Price Target from $32.00 to $26.00 | |
| Buy rating | 08/10/20 |
| Citigroup maintains Buy rating and lowers Price Target from $27.00 to $26.00 | |
| Underperform rating | 07/07/20 |
| B of A Securities maintains Underperform rating and raises Price Target from $12.00 to $14.00 | |
| Date | 2020-08-06 (BMO) | Est. (EPS/Rev.) | $0.66/ 1.79B |
| Actual (EPS/Rev.) | $0.46/ $1.66 B | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swingtrades | R. belegger | 83.00 % | Follow |
| Analyst Rating Investments | BigMoveTrader | 67.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.